ロード中...
Update on the role of lenalidomide in patients with multiple myeloma
Lenalidomide is a derivative of thalidomide and belongs to the class of drugs known as the immunomodulatory drugs (IMiDs). The IMiDs have played a large role in improving the survival outcomes of patients with multiple myeloma. In particular, lenalidomide is currently standard of care in the newly d...
保存先:
| 出版年: | Ther Adv Hematol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6041862/ https://ncbi.nlm.nih.gov/pubmed/30013765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620718775629 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|